noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Sunshine Biopharma Inc.

SUNSHINE BIOPHARMA DISCUSSES THE PROGRESS OF ITS COVID-19 AND[...]
Sunshine Biopharma Inc.

SUNSHINE BIOPHARMA FILES A PATENT APPLICATION COVERING MRNA MOLECULES…
Sunshine Biopharma Inc.

SUNSHINE BIOPHARMA ANNOUNCES $1,361,000 IN DEBT REDUCTION

Healthcare

Sunshine Biopharma Inc.

04/05/2022 | Press release | Archived content

SUNSHINE BIOPHARMA’S NEWLY DESIGNED MRNA MOLECULES PROVE EFFECTIVE AGAINST MULTIDRUG RESISTANT CANCER CELLS

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Sunshine Biopharma Inc. | News | Health | Securities Issuers | Pharmaceutical Companies | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago

Back

Download the original document